Review



ythdf3 antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech ythdf3 antibody
    Ythdf3 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 490 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/YTHDF2+Antibody/pm41803297-239-37-27
    Average 96 stars, based on 490 article reviews
    ythdf3 antibody - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    Western Blot:

    Article Title: GAS5 Downregulation Promotes the Progression of Triple-Negative Breast Cancer by Regulating Tumor Cells-MDSCs Crosstalk.
    Article Snippet: .. One-third of the precipitated material was eluted in 1× SDS loading buffer for Western blot analysis of YTHDF2 (Proteintech, Wuhan, China). ..

    Analysis:

    Article Title: GAS5 Downregulation Promotes the Progression of Triple-Negative Breast Cancer by Regulating Tumor Cells-MDSCs Crosstalk.
    Article Snippet: .. One-third of the precipitated material was eluted in 1× SDS loading buffer for Western blot analysis of YTHDF2 (Proteintech, Wuhan, China). ..

    Chloramphenicol Acetyltransferase Assay:

    Article Title: PADI2 facilitates progression and cisplatin resistance of epithelial ovarian cancer via m6A methylation
    Article Snippet: .. YTHDF2 , Proteintech , CAT81340-1-RR; RRID: AB_2923715. .. GAPDH , Proteintech , CAT#CL594-60004; RRID: AB_2919886.

    Incubation:

    Article Title: M6A-modified Gata1 promotes endoplasmic reticulum stress during acute kidney injury via suppressing Sesn2 : Gata1 promotes acute kidney injury by downregulating Sesn2.
    Article Snippet: 1 Department of Hematology, The Second Xiangya Hospital, Changsha 410000, Hunan province, PR China 2 Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, PR China 3 Department of Nephrology, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Hunan Clinical Research Center for Chronic Kidney Disease, Changsha 410000, Hunan province, PR China 4 Clinical Nursing Teaching and Research Section, The Second XiangYa Hospital of Central South University, Changsha 410011, Hunan, China 5 Department of Nephrology, The First Affiliated Hospital of Changde Vocational Technical College, Changde 415000, Hunan province, PR China 6 Department of Nephrology, The Second Xiangya Hospital, Key Lab of Kidney Disease and Blood Purification in Hunan, Central South University, Changsha 410000, Hunan province, PR China 7 National Clinical Research Center for Metabolic Diseases, Changsha 410000, Hunan province, PR China Abstract Renal ischemia/reperfusion (I/R) is a leading cause of acute kidney injury (AKI), which is closely related to endoplasmic reticulum stress (ERS).. Gata binding protein 1 (Gata1) has been reported to be involved in ERS, but its role in renal tubular epithelial cell ERS under AKI conditions remains elusive.. In this study, renal I/R-induced mouse model and hypoxia/reoxygenation (H/R)-induced TCMK-1 cell model were established.

    Article Title: YTHDF2 Contributes to Postoperative Cognitive Dysfunction Following Femoral Fracture.
    Article Snippet: Postoperative cognitive dysfunction (POCD) is a prevalent neurological complication in older patients undergoing orthopedic surgery.. N6-methyladenine (m6A) modification regulates central nervous system development and neuroinflammation.. However, its specific role in POCD remains poorly understood.

    Article Title: Helicobacter pylori CagA effector protein drives gastric cancer progression via m6A/DUSP6-mediated regulation of tumor glycolysis
    Article Snippet: Proteins were separated by 15% SDS-PAGE and subsequently transferred onto nitrocellulose membranes (Pall Corporation, USA). .. The membranes were blocked with 5% skim milk in Tris-buffered saline with Tween 20 (TBST) for 2 hours at room temperature, followed by overnight incubation at 4 °C with specific primary antibodies: METTL3 (15073- 1-AP, Proteintech, Wuhan, China, 1:1000), USP7 (66514-1-Ig, Proteintech, 1:1000), YTHDF2 (24744-1-AP, Proteintech, 1:3000), DUSP6 (R381008, Zenbio, Chengdu, China, 1:500), GAPDH (10494-1-AP, Proteintech, 1:5000), METTL14 (A8530, ABclonal, Wuhan, China, 1:1000), WTAP (10200-1-AP, Proteintech, 1:1000), YTHDF1 (19834-1-AP, Proteintech, 1:3000), and GFP-tag (50430-2-AP, Proteintech, 1:2000). .. After three washes with TBST, the membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (Proteintech, 1:5000) for 1 hour at room temperature.

    Cell-Signaling:

    Article Title: M6A-modified Gata1 promotes endoplasmic reticulum stress during acute kidney injury via suppressing Sesn2 : Gata1 promotes acute kidney injury by downregulating Sesn2.
    Article Snippet: 1 Department of Hematology, The Second Xiangya Hospital, Changsha 410000, Hunan province, PR China 2 Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, PR China 3 Department of Nephrology, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Hunan Clinical Research Center for Chronic Kidney Disease, Changsha 410000, Hunan province, PR China 4 Clinical Nursing Teaching and Research Section, The Second XiangYa Hospital of Central South University, Changsha 410011, Hunan, China 5 Department of Nephrology, The First Affiliated Hospital of Changde Vocational Technical College, Changde 415000, Hunan province, PR China 6 Department of Nephrology, The Second Xiangya Hospital, Key Lab of Kidney Disease and Blood Purification in Hunan, Central South University, Changsha 410000, Hunan province, PR China 7 National Clinical Research Center for Metabolic Diseases, Changsha 410000, Hunan province, PR China Abstract Renal ischemia/reperfusion (I/R) is a leading cause of acute kidney injury (AKI), which is closely related to endoplasmic reticulum stress (ERS).. Gata binding protein 1 (Gata1) has been reported to be involved in ERS, but its role in renal tubular epithelial cell ERS under AKI conditions remains elusive.. In this study, renal I/R-induced mouse model and hypoxia/reoxygenation (H/R)-induced TCMK-1 cell model were established.

    Magnetic Beads:

    Article Title: M6A-modified Gata1 promotes endoplasmic reticulum stress during acute kidney injury via suppressing Sesn2 : Gata1 promotes acute kidney injury by downregulating Sesn2.
    Article Snippet: 1 Department of Hematology, The Second Xiangya Hospital, Changsha 410000, Hunan province, PR China 2 Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan, PR China 3 Department of Nephrology, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Hunan Clinical Research Center for Chronic Kidney Disease, Changsha 410000, Hunan province, PR China 4 Clinical Nursing Teaching and Research Section, The Second XiangYa Hospital of Central South University, Changsha 410011, Hunan, China 5 Department of Nephrology, The First Affiliated Hospital of Changde Vocational Technical College, Changde 415000, Hunan province, PR China 6 Department of Nephrology, The Second Xiangya Hospital, Key Lab of Kidney Disease and Blood Purification in Hunan, Central South University, Changsha 410000, Hunan province, PR China 7 National Clinical Research Center for Metabolic Diseases, Changsha 410000, Hunan province, PR China Abstract Renal ischemia/reperfusion (I/R) is a leading cause of acute kidney injury (AKI), which is closely related to endoplasmic reticulum stress (ERS).. Gata binding protein 1 (Gata1) has been reported to be involved in ERS, but its role in renal tubular epithelial cell ERS under AKI conditions remains elusive.. In this study, renal I/R-induced mouse model and hypoxia/reoxygenation (H/R)-induced TCMK-1 cell model were established.

    Suspension:

    Article Title: YTHDF2 Contributes to Postoperative Cognitive Dysfunction Following Femoral Fracture.
    Article Snippet: Postoperative cognitive dysfunction (POCD) is a prevalent neurological complication in older patients undergoing orthopedic surgery.. N6-methyladenine (m6A) modification regulates central nervous system development and neuroinflammation.. However, its specific role in POCD remains poorly understood.

    Saline:

    Article Title: Helicobacter pylori CagA effector protein drives gastric cancer progression via m6A/DUSP6-mediated regulation of tumor glycolysis
    Article Snippet: Proteins were separated by 15% SDS-PAGE and subsequently transferred onto nitrocellulose membranes (Pall Corporation, USA). .. The membranes were blocked with 5% skim milk in Tris-buffered saline with Tween 20 (TBST) for 2 hours at room temperature, followed by overnight incubation at 4 °C with specific primary antibodies: METTL3 (15073- 1-AP, Proteintech, Wuhan, China, 1:1000), USP7 (66514-1-Ig, Proteintech, 1:1000), YTHDF2 (24744-1-AP, Proteintech, 1:3000), DUSP6 (R381008, Zenbio, Chengdu, China, 1:500), GAPDH (10494-1-AP, Proteintech, 1:5000), METTL14 (A8530, ABclonal, Wuhan, China, 1:1000), WTAP (10200-1-AP, Proteintech, 1:1000), YTHDF1 (19834-1-AP, Proteintech, 1:3000), and GFP-tag (50430-2-AP, Proteintech, 1:2000). .. After three washes with TBST, the membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (Proteintech, 1:5000) for 1 hour at room temperature.

    other:

    Article Title: RNA Modification Profiles and m 6 A Regulatory Patterns in the Lungs of Sheep at Different Altitudes
    Article Snippet: YTHDF2 , Proteintech , 24744-1-AP , 1:5000.



    Similar Products

    96
    Proteintech ythdf3
    The antibodies used in this study for Western blot.
    Ythdf3, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/YTHDF3-specific+Antibody/pmc13761495-9-0-2
    Average 96 stars, based on 1 article reviews
    ythdf3 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology anti ythdf3
    The antibodies used in this study for Western blot.
    Anti Ythdf3, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/YTHDF3+Rabbit+pAb/pmc13677005-213-0-18
    Average 94 stars, based on 1 article reviews
    anti ythdf3 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Proteintech rabbit anti ythdf3
    The antibodies used in this study for Western blot.
    Rabbit Anti Ythdf3, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/YTHDF3-specific+Antibody/pm42533115-85-81-85
    Average 96 stars, based on 1 article reviews
    rabbit anti ythdf3 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    86
    Genechem control ythdf3 nc lentiviruses
    The antibodies used in this study for Western blot.
    Control Ythdf3 Nc Lentiviruses, supplied by Genechem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/lentiviral+particles/pm42235938-78-5-12
    Average 86 stars, based on 1 article reviews
    control ythdf3 nc lentiviruses - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Genechem ythdf3
    The antibodies used in this study for Western blot.
    Ythdf3, supplied by Genechem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/lentiviral+particles/pm42036761-64-7-11
    Average 86 stars, based on 1 article reviews
    ythdf3 - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    ABclonal Biotechnology ythdf3
    <t>YTHDF3</t> is overexpressed in breast cancer tissues and cells. (A) YTHDF3 expression in breast cancer tissues and adjacent normal tissues in TCGA database; (B) YTHDF3 expression in different types of breast cancer in TCGA database; (C) Kaplan–Meier curves of OS in the TCGA dataset of all breast cancer patients with high and low YTHDF3 expression; (D) YTHDF3 expression in paired breast cancer tissues and adjacent normal tissues; (E) YTHDF3 expression of breast cancer and para‐cancerous tissues was evaluated by immunohistochemistry, ×100; (F) YTHDF3 protein expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453; (G) Relative YTHDF3 mRNA expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453.
    Ythdf3, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/YTHDF3+Rabbit+pAb/pmc13111412-81-45-47
    Average 94 stars, based on 1 article reviews
    ythdf3 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Shanghai Genechem Ltd ythdf3 shrna lentiviruses
    <t>YTHDF3</t> is overexpressed in breast cancer tissues and cells. (A) YTHDF3 expression in breast cancer tissues and adjacent normal tissues in TCGA database; (B) YTHDF3 expression in different types of breast cancer in TCGA database; (C) Kaplan–Meier curves of OS in the TCGA dataset of all breast cancer patients with high and low YTHDF3 expression; (D) YTHDF3 expression in paired breast cancer tissues and adjacent normal tissues; (E) YTHDF3 expression of breast cancer and para‐cancerous tissues was evaluated by immunohistochemistry, ×100; (F) YTHDF3 protein expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453; (G) Relative YTHDF3 mRNA expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453.
    Ythdf3 Shrna Lentiviruses, supplied by Shanghai Genechem Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/lentiviruses+shrna+ythdf3/pm41881336-132-0-6
    Average 86 stars, based on 1 article reviews
    ythdf3 shrna lentiviruses - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc ythdf3
    <t>YTHDF3</t> is overexpressed in breast cancer tissues and cells. (A) YTHDF3 expression in breast cancer tissues and adjacent normal tissues in TCGA database; (B) YTHDF3 expression in different types of breast cancer in TCGA database; (C) Kaplan–Meier curves of OS in the TCGA dataset of all breast cancer patients with high and low YTHDF3 expression; (D) YTHDF3 expression in paired breast cancer tissues and adjacent normal tissues; (E) YTHDF3 expression of breast cancer and para‐cancerous tissues was evaluated by immunohistochemistry, ×100; (F) YTHDF3 protein expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453; (G) Relative YTHDF3 mRNA expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453.
    Ythdf3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3/YTHDF3+Antibody/pm41862833-75-34-36
    Average 94 stars, based on 1 article reviews
    ythdf3 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    The antibodies used in this study for Western blot.

    Journal: Animals : an Open Access Journal from MDPI

    Article Title: RNA Modification Profiles and m 6 A Regulatory Patterns in the Lungs of Sheep at Different Altitudes

    doi: 10.3390/ani16213393

    Figure Lengend Snippet: The antibodies used in this study for Western blot.

    Article Snippet: YTHDF3 , Proteintech , 25537-1-AP , 1:5000.

    Techniques: Western Blot

    Information on RT-qPCR primer sequences.

    Journal: Animals : an Open Access Journal from MDPI

    Article Title: RNA Modification Profiles and m 6 A Regulatory Patterns in the Lungs of Sheep at Different Altitudes

    doi: 10.3390/ani16213393

    Figure Lengend Snippet: Information on RT-qPCR primer sequences.

    Article Snippet: YTHDF3 , Proteintech , 25537-1-AP , 1:5000.

    Techniques:

    Protein and mRNA expression levels of m 6 A reader proteins in sheep lungs from different groups. ( a ) Western blot analysis of YTHDF1, YTHDF2, YTHDF3, YTHDC1, and YTHDC2 protein expression in the lungs of LL, ML, and HL groups, with ACTB used as the internal reference protein; ( b ) statistical analysis of relative protein expression levels of YTHDF1, YTHDF2, YTHDF3, YTHDC1, and YTHDC2; ( c ) RT-qPCR analysis of relative mRNA expression levels of YTHDF1 , YTHDF2 , YTHDF3 , YTHDC1 , and YTHDC2 . Statistical significance between groups is indicated as *; p < 0.05, **; p < 0.01, ns: no significant difference.

    Journal: Animals : an Open Access Journal from MDPI

    Article Title: RNA Modification Profiles and m 6 A Regulatory Patterns in the Lungs of Sheep at Different Altitudes

    doi: 10.3390/ani16213393

    Figure Lengend Snippet: Protein and mRNA expression levels of m 6 A reader proteins in sheep lungs from different groups. ( a ) Western blot analysis of YTHDF1, YTHDF2, YTHDF3, YTHDC1, and YTHDC2 protein expression in the lungs of LL, ML, and HL groups, with ACTB used as the internal reference protein; ( b ) statistical analysis of relative protein expression levels of YTHDF1, YTHDF2, YTHDF3, YTHDC1, and YTHDC2; ( c ) RT-qPCR analysis of relative mRNA expression levels of YTHDF1 , YTHDF2 , YTHDF3 , YTHDC1 , and YTHDC2 . Statistical significance between groups is indicated as *; p < 0.05, **; p < 0.01, ns: no significant difference.

    Article Snippet: YTHDF3 , Proteintech , 25537-1-AP , 1:5000.

    Techniques: Expressing, Western Blot, Analysis, Quantitative RT-PCR

    YTHDF3 is overexpressed in breast cancer tissues and cells. (A) YTHDF3 expression in breast cancer tissues and adjacent normal tissues in TCGA database; (B) YTHDF3 expression in different types of breast cancer in TCGA database; (C) Kaplan–Meier curves of OS in the TCGA dataset of all breast cancer patients with high and low YTHDF3 expression; (D) YTHDF3 expression in paired breast cancer tissues and adjacent normal tissues; (E) YTHDF3 expression of breast cancer and para‐cancerous tissues was evaluated by immunohistochemistry, ×100; (F) YTHDF3 protein expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453; (G) Relative YTHDF3 mRNA expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: YTHDF3 Mediates the Occurrence and Development of Breast Cancer by Regulating Glycolysis Through the mTOR – HIF1α – LHDA Axis

    doi: 10.1111/jcmm.71105

    Figure Lengend Snippet: YTHDF3 is overexpressed in breast cancer tissues and cells. (A) YTHDF3 expression in breast cancer tissues and adjacent normal tissues in TCGA database; (B) YTHDF3 expression in different types of breast cancer in TCGA database; (C) Kaplan–Meier curves of OS in the TCGA dataset of all breast cancer patients with high and low YTHDF3 expression; (D) YTHDF3 expression in paired breast cancer tissues and adjacent normal tissues; (E) YTHDF3 expression of breast cancer and para‐cancerous tissues was evaluated by immunohistochemistry, ×100; (F) YTHDF3 protein expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453; (G) Relative YTHDF3 mRNA expression in normal human breast cell line MCF‐10A and breast cancer cell lines MCF‐7, MDA‐MB‐231, SK‐BR‐3, ZR‐75‐1 and MDA‐MB‐453.

    Article Snippet: Primary antibodies used in the present study were listed as follows: GAPDH (ab313650, Abcam), HIF1 alpha (ab1, Abcam), mTOR (BM4182, Boster), p‐mTOR (BM4840, Boster), RICTOR (A03195‐1, Boster), RAPTOR (BM4438, Boster), AKT (BM4390, Boster), p‐AKT (BM4744, Boster), S6K (BM4240, Boster), p‐S6K (BM4141, Boster), LDHA (A1146, ABclonal), YTHDF3 (A8395, ABclonal), cyclin D1 (A11022, ABclonal), CDK4 (A23522, ABclonal), vimentin ( PAB48967 , Bioswamp), MMP9 (FNab05247, FineTest), LDHB (A5131, ABclonal), PKM1/2 (A27199PM, ABclonal), PFKL (A23687, ABclonal), snail (13099–1‐AP, Proteintech), E‐cadherin (PB9561, Boster), N‐cadherin (A01577‐3, Boster).

    Techniques: Expressing, Immunohistochemistry

    Silence of YTHDF3 restrain cell proliferation and migration of breast cancer cells and arrested the cell cycle. (A) Relative expression of YTHDF3 mRNA and protein after transfection of shNC and shYTHDF3 in MDA‐MB‐231 and MCF‐7 cells; (B) the growth ability of MDA‐MB‐231 and MCF‐7 cells transfected with shNC and shYTHDF3 was detected by CCK‐8 assay; (C) colony formation assay was used to detect the proliferation ability of MDA‐MB‐231 and MCF‐7 cells in shNC and shYTHDF3 groups; (D) the cell cycle distribution of MDA‐MB‐231 and MCF‐7 cells in shNC and shYTHDF3 groups was detected by flow cytometry; (E) expression of cyclin D1 and CDK4 in shNC and shYTHDF3 in MDA‐MB‐231 and MCF‐7 cells; (F, G) transwell invasion assay was used to detect the migration ability of breast cancer cells in the shNC group and the shYTHDF3 group in MCF‐7 and MDA‐MB‐231 cells; (H) the expression of vimentin, MMP9, E‐cadherin, N‐cadherin and snail in shNC and shYTHDF3 in MDA‐MB‐231 and MCF‐7 cells.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: YTHDF3 Mediates the Occurrence and Development of Breast Cancer by Regulating Glycolysis Through the mTOR – HIF1α – LHDA Axis

    doi: 10.1111/jcmm.71105

    Figure Lengend Snippet: Silence of YTHDF3 restrain cell proliferation and migration of breast cancer cells and arrested the cell cycle. (A) Relative expression of YTHDF3 mRNA and protein after transfection of shNC and shYTHDF3 in MDA‐MB‐231 and MCF‐7 cells; (B) the growth ability of MDA‐MB‐231 and MCF‐7 cells transfected with shNC and shYTHDF3 was detected by CCK‐8 assay; (C) colony formation assay was used to detect the proliferation ability of MDA‐MB‐231 and MCF‐7 cells in shNC and shYTHDF3 groups; (D) the cell cycle distribution of MDA‐MB‐231 and MCF‐7 cells in shNC and shYTHDF3 groups was detected by flow cytometry; (E) expression of cyclin D1 and CDK4 in shNC and shYTHDF3 in MDA‐MB‐231 and MCF‐7 cells; (F, G) transwell invasion assay was used to detect the migration ability of breast cancer cells in the shNC group and the shYTHDF3 group in MCF‐7 and MDA‐MB‐231 cells; (H) the expression of vimentin, MMP9, E‐cadherin, N‐cadherin and snail in shNC and shYTHDF3 in MDA‐MB‐231 and MCF‐7 cells.

    Article Snippet: Primary antibodies used in the present study were listed as follows: GAPDH (ab313650, Abcam), HIF1 alpha (ab1, Abcam), mTOR (BM4182, Boster), p‐mTOR (BM4840, Boster), RICTOR (A03195‐1, Boster), RAPTOR (BM4438, Boster), AKT (BM4390, Boster), p‐AKT (BM4744, Boster), S6K (BM4240, Boster), p‐S6K (BM4141, Boster), LDHA (A1146, ABclonal), YTHDF3 (A8395, ABclonal), cyclin D1 (A11022, ABclonal), CDK4 (A23522, ABclonal), vimentin ( PAB48967 , Bioswamp), MMP9 (FNab05247, FineTest), LDHB (A5131, ABclonal), PKM1/2 (A27199PM, ABclonal), PFKL (A23687, ABclonal), snail (13099–1‐AP, Proteintech), E‐cadherin (PB9561, Boster), N‐cadherin (A01577‐3, Boster).

    Techniques: Migration, Expressing, Transfection, CCK-8 Assay, Colony Assay, Flow Cytometry, Transwell Invasion Assay

    Silencing YTHDF3 caused a decrease in lactate levels and affected glycolysis. (A) Lactate levels in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (B) extracellular acidification rate (ECAR) in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells measured by a seahorse instrument; (C) oxygen consumption rate (OCR) in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells measured by a seahorse instrument; (D) relative expression levels of hexokinase‐1 (HK1), hexokinase‐2 (HK2), PFKL, PKM, LDHA and LDHB in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (E) protein expression levels of PFKL, PKM, LDHA and LDHB in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; and (F) the correlation between YTHDF3 and PFKL, PKM, LDHA and LDHB was predicted using the GEPIA website.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: YTHDF3 Mediates the Occurrence and Development of Breast Cancer by Regulating Glycolysis Through the mTOR – HIF1α – LHDA Axis

    doi: 10.1111/jcmm.71105

    Figure Lengend Snippet: Silencing YTHDF3 caused a decrease in lactate levels and affected glycolysis. (A) Lactate levels in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (B) extracellular acidification rate (ECAR) in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells measured by a seahorse instrument; (C) oxygen consumption rate (OCR) in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells measured by a seahorse instrument; (D) relative expression levels of hexokinase‐1 (HK1), hexokinase‐2 (HK2), PFKL, PKM, LDHA and LDHB in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (E) protein expression levels of PFKL, PKM, LDHA and LDHB in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; and (F) the correlation between YTHDF3 and PFKL, PKM, LDHA and LDHB was predicted using the GEPIA website.

    Article Snippet: Primary antibodies used in the present study were listed as follows: GAPDH (ab313650, Abcam), HIF1 alpha (ab1, Abcam), mTOR (BM4182, Boster), p‐mTOR (BM4840, Boster), RICTOR (A03195‐1, Boster), RAPTOR (BM4438, Boster), AKT (BM4390, Boster), p‐AKT (BM4744, Boster), S6K (BM4240, Boster), p‐S6K (BM4141, Boster), LDHA (A1146, ABclonal), YTHDF3 (A8395, ABclonal), cyclin D1 (A11022, ABclonal), CDK4 (A23522, ABclonal), vimentin ( PAB48967 , Bioswamp), MMP9 (FNab05247, FineTest), LDHB (A5131, ABclonal), PKM1/2 (A27199PM, ABclonal), PFKL (A23687, ABclonal), snail (13099–1‐AP, Proteintech), E‐cadherin (PB9561, Boster), N‐cadherin (A01577‐3, Boster).

    Techniques: Expressing

    YTHDF3 regulates the glycolysis level of breast cancer through the mTOR–HIF1α–LDHA axis. (A) Relative mRNA expression of HIF1α in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (B) the correlation between YTHDF3 and HIF1α was predicted using the GEPIA website; (C) expression of key proteins in the mTOR–HIF1α–LDHA axis in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (D) after adding activator MHY1445, the growth ability of cancer cells in shNC and shYTHDF3 groups was detected by CCK‐8 assay; (E) the lactate level of cancer cells in shNC and shYTHDF3 groups treated with activator MHY1485; and (F) expression of proteins of cancer cells in shNC and shYTHDF3 groups treated with activator MHY1485.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: YTHDF3 Mediates the Occurrence and Development of Breast Cancer by Regulating Glycolysis Through the mTOR – HIF1α – LHDA Axis

    doi: 10.1111/jcmm.71105

    Figure Lengend Snippet: YTHDF3 regulates the glycolysis level of breast cancer through the mTOR–HIF1α–LDHA axis. (A) Relative mRNA expression of HIF1α in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (B) the correlation between YTHDF3 and HIF1α was predicted using the GEPIA website; (C) expression of key proteins in the mTOR–HIF1α–LDHA axis in shNC and shYTHDF3 groups in MDA‐MB‐231 and MCF‐7 cells; (D) after adding activator MHY1445, the growth ability of cancer cells in shNC and shYTHDF3 groups was detected by CCK‐8 assay; (E) the lactate level of cancer cells in shNC and shYTHDF3 groups treated with activator MHY1485; and (F) expression of proteins of cancer cells in shNC and shYTHDF3 groups treated with activator MHY1485.

    Article Snippet: Primary antibodies used in the present study were listed as follows: GAPDH (ab313650, Abcam), HIF1 alpha (ab1, Abcam), mTOR (BM4182, Boster), p‐mTOR (BM4840, Boster), RICTOR (A03195‐1, Boster), RAPTOR (BM4438, Boster), AKT (BM4390, Boster), p‐AKT (BM4744, Boster), S6K (BM4240, Boster), p‐S6K (BM4141, Boster), LDHA (A1146, ABclonal), YTHDF3 (A8395, ABclonal), cyclin D1 (A11022, ABclonal), CDK4 (A23522, ABclonal), vimentin ( PAB48967 , Bioswamp), MMP9 (FNab05247, FineTest), LDHB (A5131, ABclonal), PKM1/2 (A27199PM, ABclonal), PFKL (A23687, ABclonal), snail (13099–1‐AP, Proteintech), E‐cadherin (PB9561, Boster), N‐cadherin (A01577‐3, Boster).

    Techniques: Expressing, CCK-8 Assay

    YTHDF3 regulates breast cancer development through the mTOR–HIF1α–LDHA axis in vivo. (A) Tumour volumes in shNC and shYTHDF3 groups on the indicated days; (B) representative tumour images and (C) tumour weights in shNC and shYTHDF3 groups on day 63; (D) mRNA and (E) protein expression levels of YTHDF3, HIF1α and LDHA in the tumours in shNC and shYTHDF3 groups; (F) Immunohistochemical images of YTHDF3, Ki67, HIF1α and LDHA in tumours in the shNC and shYTHDF3 groups, ×100.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: YTHDF3 Mediates the Occurrence and Development of Breast Cancer by Regulating Glycolysis Through the mTOR – HIF1α – LHDA Axis

    doi: 10.1111/jcmm.71105

    Figure Lengend Snippet: YTHDF3 regulates breast cancer development through the mTOR–HIF1α–LDHA axis in vivo. (A) Tumour volumes in shNC and shYTHDF3 groups on the indicated days; (B) representative tumour images and (C) tumour weights in shNC and shYTHDF3 groups on day 63; (D) mRNA and (E) protein expression levels of YTHDF3, HIF1α and LDHA in the tumours in shNC and shYTHDF3 groups; (F) Immunohistochemical images of YTHDF3, Ki67, HIF1α and LDHA in tumours in the shNC and shYTHDF3 groups, ×100.

    Article Snippet: Primary antibodies used in the present study were listed as follows: GAPDH (ab313650, Abcam), HIF1 alpha (ab1, Abcam), mTOR (BM4182, Boster), p‐mTOR (BM4840, Boster), RICTOR (A03195‐1, Boster), RAPTOR (BM4438, Boster), AKT (BM4390, Boster), p‐AKT (BM4744, Boster), S6K (BM4240, Boster), p‐S6K (BM4141, Boster), LDHA (A1146, ABclonal), YTHDF3 (A8395, ABclonal), cyclin D1 (A11022, ABclonal), CDK4 (A23522, ABclonal), vimentin ( PAB48967 , Bioswamp), MMP9 (FNab05247, FineTest), LDHB (A5131, ABclonal), PKM1/2 (A27199PM, ABclonal), PFKL (A23687, ABclonal), snail (13099–1‐AP, Proteintech), E‐cadherin (PB9561, Boster), N‐cadherin (A01577‐3, Boster).

    Techniques: In Vivo, Expressing, Immunohistochemical staining

    YTHDF3 is associated with prognosis in several cancers. (A) Column nomogram was constructed using YTHDF3 expression levels, age, T stage, N stage, M stage and tumour stage data of breast cancer patients; (B–E) survival analysis software package was used to analyse the survival prognosis difference between patients with high and low YTHDF3 expression in BRCA, DLBC, THCA and UVM.

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: YTHDF3 Mediates the Occurrence and Development of Breast Cancer by Regulating Glycolysis Through the mTOR – HIF1α – LHDA Axis

    doi: 10.1111/jcmm.71105

    Figure Lengend Snippet: YTHDF3 is associated with prognosis in several cancers. (A) Column nomogram was constructed using YTHDF3 expression levels, age, T stage, N stage, M stage and tumour stage data of breast cancer patients; (B–E) survival analysis software package was used to analyse the survival prognosis difference between patients with high and low YTHDF3 expression in BRCA, DLBC, THCA and UVM.

    Article Snippet: Primary antibodies used in the present study were listed as follows: GAPDH (ab313650, Abcam), HIF1 alpha (ab1, Abcam), mTOR (BM4182, Boster), p‐mTOR (BM4840, Boster), RICTOR (A03195‐1, Boster), RAPTOR (BM4438, Boster), AKT (BM4390, Boster), p‐AKT (BM4744, Boster), S6K (BM4240, Boster), p‐S6K (BM4141, Boster), LDHA (A1146, ABclonal), YTHDF3 (A8395, ABclonal), cyclin D1 (A11022, ABclonal), CDK4 (A23522, ABclonal), vimentin ( PAB48967 , Bioswamp), MMP9 (FNab05247, FineTest), LDHB (A5131, ABclonal), PKM1/2 (A27199PM, ABclonal), PFKL (A23687, ABclonal), snail (13099–1‐AP, Proteintech), E‐cadherin (PB9561, Boster), N‐cadherin (A01577‐3, Boster).

    Techniques: Construct, Expressing, Software